Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
2003 1
2004 3
2005 2
2006 1
2008 1
2009 2
2010 3
2011 2
2012 5
2013 9
2014 6
2015 8
2016 4
2017 6
2018 7
2019 10
2020 19
2021 13
2022 13
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean m naseri (310 results)?
Who are the Best Scientists in Tunisia? Analysis of the 2023 edition of the “Research.com” platform.
Ben Abdelaziz A, Ben Abdelaziz A, Zanina Y, Ben Hassine D, Melki S, Khelil M. Ben Abdelaziz A, et al. Tunis Med. 2023 Dec 5;101(12):871-878. Tunis Med. 2023. PMID: 38477193 French.
These researchers were attached to seven establishments including the universities of "Sfax" and "Monastir" and the "Borj Cedria - Sidi Thabet Biotechnology Center". Among these winners: Professors Moncef NASRI (Sfax, "Biology and Biochemistry", D-index=74), Chedly ABDELLY …
These researchers were attached to seven establishments including the universities of "Sfax" and "Monastir" and the "Borj Cedria - Sidi Thab …
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. ...Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. ...
Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gaz …
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development.
Paganoni S, Berry JD, Quintana M, Macklin E, Saville BR, Detry MA, Chase M, Sherman AV, Yu H, Drake K, Andrews J, Shefner J, Chibnik LB, Vestrucci M, Cudkowicz ME; Healey ALS Platform Trial Study Group. Paganoni S, et al. Ann Neurol. 2022 Feb;91(2):165-175. doi: 10.1002/ana.26285. Epub 2022 Jan 10. Ann Neurol. 2022. PMID: 34935174 Review.
Targeted therapy in eosinophilic chronic obstructive pulmonary disease.
Fieldes M, Bourguignon C, Assou S, Nasri A, Fort A, Vachier I, De Vos J, Ahmed E, Bourdin A. Fieldes M, et al. ERJ Open Res. 2021 Apr 12;7(2):00437-2020. doi: 10.1183/23120541.00437-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33855061 Free PMC article. Review.
β-Nb9VO25.
Nasri R, Chérif SF, Zid MF, Driss A. Nasri R, et al. Acta Crystallogr Sect E Struct Rep Online. 2014 Apr 16;70(Pt 5):i20. doi: 10.1107/S1600536814007831. eCollection 2014 May 1. Acta Crystallogr Sect E Struct Rep Online. 2014. PMID: 24860297 Free PMC article.
It is isotypic with Nb9AsO25, Nb9PO25 and Ta9VO25. The structure consists of NbO6 octa-hedra (one with 4/m.. and two with m.. symmetry) and VO4 tetra-hedra (-4.. symmetry) sharing corners and edges to form a three-dimensional framework. ...
It is isotypic with Nb9AsO25, Nb9PO25 and Ta9VO25. The structure consists of NbO6 octa-hedra (one with 4/m.. and two with m.. …
Real-life use of tolvaptan in ADPKD: a retrospective analysis of a large Canadian cohort.
Calvaruso L, Yau K, Akbari P, Nasri F, Khowaja S, Wang B, Haghighi A, Khalili K, Pei Y. Calvaruso L, et al. Sci Rep. 2023 Dec 14;13(1):22257. doi: 10.1038/s41598-023-48638-9. Sci Rep. 2023. PMID: 38097698 Free PMC article.
Among these high-risk patients, those not treated versus treated with tolvaptan were more likely to have a higher eGFR (82 26 vs. 61 27 ml/min/1.73 m(2)), CKD stages 1-2 (79% vs. 41%), and MCIC 1C (63% vs. 31%). ...
Among these high-risk patients, those not treated versus treated with tolvaptan were more likely to have a higher eGFR (82 26 vs. 61 27 ml/m …
Extracapillary proliferation in IgA nephropathy; recent findings and new ideas.
Nasri H, Mubarak M. Nasri H, et al. J Nephropathol. 2015 Jan;4(1):1-5. doi: 10.12860/jnp.2015.01. Epub 2015 Jan 1. J Nephropathol. 2015. PMID: 25657978 Free PMC article. Review.
This classification, containing four pathology variables, was found to have prognostic implications. The variables included are mesangial hypercellularity (M), endocapillary proliferation (E), segmental glomerulosclerosis (S) and the proportion of interstitial fibrosis and …
This classification, containing four pathology variables, was found to have prognostic implications. The variables included are mesangial hy …
SARS-CoV-2 Seroprevalence among Health-Care Workers in Isfahan, Iran.
Rostami S, Haghjooy Javanmard S, Nokhodian Z, Kassaian N, Zamani A, Tahvilian Z, Nasri P, Nasirian M, Ataei B. Rostami S, et al. Adv Biomed Res. 2023 Feb 25;12:31. doi: 10.4103/abr.abr_201_21. eCollection 2023. Adv Biomed Res. 2023. PMID: 37057248 Free PMC article.
In this study, we investigated the anti-SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) and also the associated risk factors in the HCWs working in Isfahan University of Medical Sciences COVID-19 referral hospitals. ...
In this study, we investigated the anti-SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) and also the associated risk fac …
112 results